NPPB and hydrops fetalis: When applying strict trial criteria,30% of HFpEF patients were eligible for treatment according to the DELIVERcriteria and 32% were eligible according to the EMPEROR-Preserved criteria,mainly limited by HF duration and NT-proBNP levels.